{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T06:58:19Z","timestamp":1794812299131,"version":"4.9.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004820","name":"Mochida Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004820","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Endometriosis is considered to be the most intractable cause of female infertility. Administering any type of treatment for endometriosis before in vitro fertilization and embryo transfer (IVF-ET) is an important strategy for improving the IVF-ET outcomes for infertile women with endometriosis. In fact, treatment with a gonadotropin-releasing hormone (GnRH) agonist just before IVF-ET has been reported to improve the clinical outcome in endometriosis patients. However, the benefit of Dienogest (DNG), a synthetic progestin, treatment just before IVF-ET remains unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Sixty-eight infertile women with Stage III or IV endometriosis (ovarian endometrial cyst &lt;\u20094\u2009cm) were recruited for this study. The subjects were divided into 2 groups: a DNG group (<jats:italic>n<\/jats:italic>\u2009=\u200933) and a control group (<jats:italic>n<\/jats:italic>\u2009=\u200935). DNG was administered orally every day for 12\u2009weeks prior to the conventional IVF-ET cycle in the DNG group. Standard controlled ovarian hyperstimulation with the GnRH agonist long protocol was performed in the control group. The numbers of mature follicles and retrieved oocytes, fertilization rates, implantation rates, and clinical pregnancy rate were compared between the two groups. In addition, the concentrations of inflammatory cytokines, oxidative stress markers, and antioxidants in follicular fluids were also measured.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The numbers of growing follicles, retrieved oocytes, fertilized oocytes, and blastocysts were significantly lower in the DNG group than in the control group. The fertilization and blastocyst rates were also lower in the DNG group than in the control group. Although there was no significant difference in the implantation rate between the groups, the cumulative pregnancy rate and live birth rate were lower in the DNG group than in the control group. There was no significant difference in the abortion rate. Our results failed to show that DNG reduces the inflammatory cytokine levels and oxidative stress in follicular fluids.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Administering DNG treatment just before IVF-ET did not provide any benefits to improve the clinical outcomes for infertile women with endometriosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-019-0597-y","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T17:05:02Z","timestamp":1576170302000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["The clinical outcome of Dienogest treatment followed by in vitro fertilization and embryo transfer in infertile women with endometriosis"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6258-4572","authenticated-orcid":false,"given":"Hiroshi","family":"Tamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Josaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Mihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichro","family":"Shirafuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Shinagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Taketani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Takasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Sugino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"key":"597_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrendo.2013.255","volume":"10","author":"P Vercellini","year":"2014","unstructured":"Vercellini P, Vigano P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10:261\u201375.","journal-title":"Nat Rev Endocrinol"},{"key":"597_CR2","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1056\/NEJMcp1000274","volume":"362","author":"LC Giudice","year":"2010","unstructured":"Giudice LC. Clinical practice. Endometriosis. N Engl J Med. 2010;362:2389\u201398.","journal-title":"N Engl J Med"},{"key":"597_CR3","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/oxfordjournals.aje.a114634","volume":"125","author":"DE Houston","year":"1987","unstructured":"Houston DE, Noller KL, Melton LJ 3rd, Selwyn BJ, Hardy RJ. Incidence of pelvic endometriosis in Rochester, Minnesota, 1970-1979. Am J Epidemiol. 1987;125:959\u201369.","journal-title":"Am J Epidemiol"},{"key":"597_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bpobgyn.2018.01.019","volume":"51","author":"F Prefumo","year":"2018","unstructured":"Prefumo F, Rossi AC. Endometriosis, endometrioma, and ART results: current understanding and recommended practices. Best Pract Res Clin Obstet Gynaecol. 2018;51:34\u201340.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"597_CR5","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/S0015-0282(02)03112-6","volume":"77","author":"K Barnhart","year":"2002","unstructured":"Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril. 2002;77:1148\u201355.","journal-title":"Fertil Steril"},{"key":"597_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/humupd\/8.1.79","volume":"8","author":"A Bergqvist","year":"2002","unstructured":"Bergqvist A, D'Hooghe T. Mini symposium on pathogenesis of endometriosis and treatment of endometriosis-associated subfertility. Introduction: the endometriosis enigma. Hum Reprod Update. 2002;8:79\u201383.","journal-title":"Hum Reprod Update"},{"key":"597_CR7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/humupd\/dmt024","volume":"19","author":"VJ Young","year":"2013","unstructured":"Young VJ, Brown JK, Saunders PT, Horne AW. The role of the peritoneum in the pathogenesis of endometriosis. Hum Reprod Update. 2013;19:558\u201369.","journal-title":"Hum Reprod Update"},{"key":"597_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.fertnstert.2008.02.093","volume":"90","author":"S Gupta","year":"2008","unstructured":"Gupta S, Goldberg JM, Aziz N, Goldberg E, Krajcir N, et al. Pathogenic mechanisms in endometriosis-associated infertility. Fertil Steril. 2008;90:247\u201357.","journal-title":"Fertil Steril"},{"issue":"Suppl 1","key":"597_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000049420","volume":"53","author":"T Iwabe","year":"2002","unstructured":"Iwabe T, Harada T, Terakawa N. Role of cytokines in endometriosis-associated infertility. Gynecol Obstet Investig. 2002;53(Suppl 1):19\u201325.","journal-title":"Gynecol Obstet Investig"},{"key":"597_CR10","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/rmb2.12047","volume":"16","author":"KY Hsiao","year":"2017","unstructured":"Hsiao KY, Wu MH, Tsai SJ. Epigenetic regulation of the pathological process in endometriosis. Reprod Med Biol. 2017;16:314\u20139.","journal-title":"Reprod Med Biol"},{"key":"597_CR11","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00404-012-2439-7","volume":"286","author":"LF Carvalho","year":"2012","unstructured":"Carvalho LF, Samadder AN, Agarwal A, Fernandes LF, Abrao MS. Oxidative stress biomarkers in patients with endometriosis: systematic review. Arch Gynecol Obstet. 2012;286:1033\u201340.","journal-title":"Arch Gynecol Obstet"},{"key":"597_CR12","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1016\/j.fertnstert.2009.08.068","volume":"93","author":"S Matsuzaki","year":"2010","unstructured":"Matsuzaki S, Schubert B. Oxidative stress status in normal ovarian cortex surrounding ovarian endometriosis. Fertil Steril. 2010;93:2431\u20132.","journal-title":"Fertil Steril"},{"key":"597_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00441-015-2339-9","volume":"364","author":"MG Da Broi","year":"2016","unstructured":"Da Broi MG, Navarro PA. Oxidative stress and oocyte quality: ethiopathogenic mechanisms of minimal\/mild endometriosis-related infertility. Cell Tissue Res. 2016;364:1\u20137.","journal-title":"Cell Tissue Res"},{"key":"597_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0015-0282(16)60483-1","volume":"51","author":"C Nezhat","year":"1989","unstructured":"Nezhat C, Crowgey S, Nezhat F. Videolaseroscopy for the treatment of endometriosis associated with infertility. Fertil Steril. 1989;51:237\u201340.","journal-title":"Fertil Steril"},{"key":"597_CR15","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1093\/humrep\/del230","volume":"21","author":"P Vercellini","year":"2006","unstructured":"Vercellini P, Fedele L, Aimi G, De Giorgi O, Consonni D, et al. Reproductive performance, pain recurrence and disease relapse after conservative surgical treatment for endometriosis: the predictive value of the current classification system. Hum Reprod. 2006;21:2679\u201385.","journal-title":"Hum Reprod"},{"key":"597_CR16","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1093\/humrep\/deu270","volume":"29","author":"L Muzii","year":"2014","unstructured":"Muzii L, Panici PB. Reply: Endometrioma excision and ovarian reserve: do assessments by antral follicle count and anti-Mullerian hormone yield contradictory results? Hum Reprod. 2014;29:2854\u20135.","journal-title":"Hum Reprod"},{"key":"597_CR17","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1210\/jc.2012-1558","volume":"97","author":"F Raffi","year":"2012","unstructured":"Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97:3146\u201354.","journal-title":"J Clin Endocrinol Metab"},{"key":"597_CR18","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.fertnstert.2012.08.009","volume":"98","author":"E Somigliana","year":"2012","unstructured":"Somigliana E, Berlanda N, Benaglia L, Vigano P, Vercellini P, et al. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimullerian hormone level modifications. Fertil Steril. 2012;98:1531\u20138.","journal-title":"Fertil Steril"},{"key":"597_CR19","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/humupd\/dmv035","volume":"21","author":"M Hamdan","year":"2015","unstructured":"Hamdan M, Dunselman G, Li TC, Cheong Y. The impact of endometrioma on IVF\/ICSI outcomes: a systematic review and meta-analysis. Hum Reprod Update. 2015;21:809\u201325.","journal-title":"Hum Reprod Update"},{"key":"597_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ejogrb.2016.02.035","volume":"209","author":"U Leone Roberti Maggiore","year":"2017","unstructured":"Leone Roberti Maggiore U, Gupta JK, Ferrero S. Treatment of endometrioma for improving fertility. Eur J Obstet Gynecol Reprod Biol. 2017;209:81\u20135.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"597_CR21","doi-asserted-by":"publisher","unstructured":"Sallam HN, Garcia-Velasco JA, Dias S, Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev. 2006:CD004635. https:\/\/doi.org\/10.1002\/14651858.CD004635.pub2.","DOI":"10.1002\/14651858.CD004635.pub2"},{"key":"597_CR22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13048-014-0100-8","volume":"7","author":"H Tamura","year":"2014","unstructured":"Tamura H, Takasaki A, Nakamura Y, Numa F, Sugino N. A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis. J Ovarian Res. 2014;7:100.","journal-title":"J Ovarian Res"},{"key":"597_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000331642","volume":"72","author":"OM Fischer","year":"2011","unstructured":"Fischer OM, Kaufmann-Reiche U, Moeller C, Fuhrmann U. Effects of dienogest on surgically induced endometriosis in rats after repeated oral administration. Gynecol Obstet Investig. 2011;72:145\u201351.","journal-title":"Gynecol Obstet Investig"},{"key":"597_CR24","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.fertnstert.2007.03.042","volume":"89","author":"L Fu","year":"2008","unstructured":"Fu L, Osuga Y, Morimoto C, Hirata T, Hirota Y, et al. Dienogest inhibits BrdU uptake with G0\/G1 arrest in cultured endometriotic stromal cells. Fertil Steril. 2008;89:1344\u20137.","journal-title":"Fertil Steril"},{"key":"597_CR25","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.fertnstert.2004.11.042","volume":"83","author":"S Horie","year":"2005","unstructured":"Horie S, Harada T, Mitsunari M, Taniguchi F, Iwabe T, et al. Progesterone and progestational compounds attenuate tumor necrosis factor alpha-induced interleukin-8 production via nuclear factor kappa B inactivation in endometriotic stromal cells. Fertil Steril. 2005;83:1530\u20135.","journal-title":"Fertil Steril"},{"key":"597_CR26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1600-079X.2011.00878.x","volume":"51","author":"T Taketani","year":"2011","unstructured":"Taketani T, Tamura H, Takasaki A, Lee L, Kizuka F, et al. Protective role of melatonin in progesterone production by human luteal cells. J Pineal Res. 2011;51:207\u201313.","journal-title":"J Pineal Res"},{"key":"597_CR27","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1600-079X.2007.00524.x","volume":"44","author":"H Tamura","year":"2008","unstructured":"Tamura H, Takasaki A, Miwa I, Taniguchi K, Maekawa R, et al. Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res. 2008;44:280\u20137.","journal-title":"J Pineal Res"},{"key":"597_CR28","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0015-0282(02)03373-3","volume":"78","author":"ES Surrey","year":"2002","unstructured":"Surrey ES, Silverberg KM, Surrey MW, Schoolcraft WB. Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril. 2002;78:699\u2013704.","journal-title":"Fertil Steril"},{"key":"597_CR29","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1095\/biolreprod57.3.580","volume":"57","author":"M Manikkam","year":"1997","unstructured":"Manikkam M, Rajamahendran R. Progesterone-induced atresia of the proestrous dominant follicle in the bovine ovary: changes in diameter, insulin-like growth factor system, aromatase activity, steroid hormones, and apoptotic index. Biol Reprod. 1997;57:580\u20137.","journal-title":"Biol Reprod"},{"key":"597_CR30","doi-asserted-by":"publisher","first-page":"850","DOI":"10.2527\/1998.763850x","volume":"76","author":"CM McDowell","year":"1998","unstructured":"McDowell CM, Anderson LH, Kinder JE, Day ML. Duration of treatment with progesterone and regression of persistent ovarian follicles in cattle. J Anim Sci. 1998;76:850\u20135.","journal-title":"J Anim Sci"},{"key":"597_CR31","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1177\/0091270011423664","volume":"52","author":"C Klipping","year":"2012","unstructured":"Klipping C, Duijkers I, Remmers A, Faustmann T, Zurth C, et al. Ovulation-inhibiting effects of dienogest in a randomized, dose-controlled pharmacodynamic trial of healthy women. J Clin Pharmacol. 2012;52:1704\u201313.","journal-title":"J Clin Pharmacol"},{"key":"597_CR32","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/BF03345616","volume":"31","author":"S Sasagawa","year":"2008","unstructured":"Sasagawa S, Shimizu Y, Nagaoka T, Tokado H, Imada K, et al. Dienogest, a selective progestin, reduces plasma estradiol level through induction of apoptosis of granulosa cells in the ovarian dominant follicle without follicle-stimulating hormone suppression in monkeys. J Endocrinol Investig. 2008;31:636\u201341.","journal-title":"J Endocrinol Investig"},{"key":"597_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.steroids.2014.10.010","volume":"93","author":"H Tsuyoshi","year":"2015","unstructured":"Tsuyoshi H, Orisaka M, Fukuda S, Hattori K, Tsang BK, et al. Protective effect of dienogest on chemotherapy-induced reduced fertility in female rats. Steroids. 2015;93:1\u20137.","journal-title":"Steroids"},{"key":"597_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jsbmb.2014.12.008","volume":"147","author":"M Ichioka","year":"2015","unstructured":"Ichioka M, Mita S, Shimizu Y, Imada K, Kiyono T, et al. Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms a and B in endometriotic cells. J Steroid Biochem Mol Biol. 2015;147:103\u201310.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"597_CR35","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1472-6483(10)60346-X","volume":"15","author":"M Bedaiwy","year":"2007","unstructured":"Bedaiwy M, Shahin AY, AbulHassan AM, Goldberg JM, Sharma RK, et al. Differential expression of follicular fluid cytokines: relationship to subsequent pregnancy in IVF cycles. Reprod BioMed Online. 2007;15:321\u20135.","journal-title":"Reprod BioMed Online"},{"key":"597_CR36","first-page":"2513","volume":"22","author":"XM Wang","year":"2018","unstructured":"Wang XM, Ma ZY, Song N. Inflammatory cytokines IL-6, IL-10, IL-13, TNF-alpha and peritoneal fluid flora were associated with infertility in patients with endometriosis. Eur Rev Med Pharmacol Sci. 2018;22:2513\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"597_CR37","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/rmb2.12028","volume":"16","author":"S Sultana","year":"2017","unstructured":"Sultana S, Kajihara T, Mizuno Y, Sato T, Oguro T, et al. Overexpression of microRNA-542-3p attenuates the differentiating capacity of endometriotic stromal cells. Reprod Med Biol. 2017;16:170\u20138.","journal-title":"Reprod Med Biol"},{"key":"597_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1447-0578.2007.00189.x","volume":"6","author":"M Irahara","year":"2007","unstructured":"Irahara M, Harada T, Momoeda M, Tamaki Y. Hormonal and histological study on irregular genital bleeding in patients with endometriosis during treatment with dienogest, a novel progestational therapeutic agent. Reprod Med Biol. 2007;6:223\u20138.","journal-title":"Reprod Med Biol"},{"key":"597_CR39","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00404-015-3681-6","volume":"292","author":"P Andres Mde","year":"2015","unstructured":"Andres Mde P, Lopes LA, Baracat EC, Podgaec S. Dienogest in the treatment of endometriosis: systematic review. Arch Gynecol Obstet. 2015;292:523\u20139.","journal-title":"Arch Gynecol Obstet"},{"key":"597_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijgo.2009.08.020","volume":"108","author":"G Kohler","year":"2010","unstructured":"Kohler G, Faustmann TA, Gerlinger C, Seitz C, Mueck AO. A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis. Int J Gynaecol Obstet. 2010;108:21\u20135.","journal-title":"Int J Gynaecol Obstet"},{"key":"597_CR41","doi-asserted-by":"publisher","first-page":"215","DOI":"10.5653\/cerm.2016.43.4.215","volume":"43","author":"SY Park","year":"2016","unstructured":"Park SY, Kim SH, Chae HD, Kim CH, Kang BM. Efficacy and safety of dienogest in patients with endometriosis: a single-center observational study over 12 months. Clin Exp Reprod Med. 2016;43:215\u201320.","journal-title":"Clin Exp Reprod Med"},{"key":"597_CR42","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.fertnstert.2016.07.1075","volume":"106","author":"J Donnez","year":"2016","unstructured":"Donnez J, Binda MM, Donnez O, Dolmans MM. Oxidative stress in the pelvic cavity and its role in the pathogenesis of endometriosis. Fertil Steril. 2016;106:1011\u20137.","journal-title":"Fertil Steril"},{"key":"597_CR43","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.fertnstert.2012.06.021","volume":"98","author":"R Gonzalez-Ramos","year":"2012","unstructured":"Gonzalez-Ramos R, Defrere S, Devoto L. Nuclear factor-kappaB: a main regulator of inflammation and cell survival in endometriosis pathophysiology. Fertil Steril. 2012;98:520\u20138.","journal-title":"Fertil Steril"},{"key":"597_CR44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/rmb2.12083","volume":"17","author":"KN Khan","year":"2018","unstructured":"Khan KN, Fujishita A, Hiraki K, Kitajima M, Nakashima M, et al. Bacterial contamination hypothesis: a new concept in endometriosis. Reprod Med Biol. 2018;17:125\u201333.","journal-title":"Reprod Med Biol"},{"key":"597_CR45","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3389\/fendo.2018.00725","volume":"9","author":"G Mate","year":"2018","unstructured":"Mate G, Bernstein LR, Torok AL. Endometriosis is a cause of infertility. Does reactive oxygen damage to gametes and embryos play a key role in the pathogenesis of infertility caused by endometriosis? Front Endocrinol (Lausanne). 2018;9:725.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"597_CR46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.fertnstert.2014.03.053","volume":"102","author":"PT Goud","year":"2014","unstructured":"Goud PT, Goud AP, Joshi N, Puscheck E, Diamond MP, et al. Dynamics of nitric oxide, altered follicular microenvironment, and oocyte quality in women with endometriosis. Fertil Steril. 2014;102:151\u20139 e155.","journal-title":"Fertil Steril"},{"key":"597_CR47","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.fertnstert.2012.03.052","volume":"98","author":"L Prieto","year":"2012","unstructured":"Prieto L, Quesada JF, Cambero O, Pacheco A, Pellicer A, et al. Analysis of follicular fluid and serum markers of oxidative stress in women with infertility related to endometriosis. Fertil Steril. 2012;98:126\u201330.","journal-title":"Fertil Steril"},{"key":"597_CR48","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.reprotox.2013.08.005","volume":"42","author":"AK Singh","year":"2013","unstructured":"Singh AK, Chattopadhyay R, Chakravarty B, Chaudhury K. Markers of oxidative stress in follicular fluid of women with endometriosis and tubal infertility undergoing IVF. Reprod Toxicol. 2013;42:116\u201324.","journal-title":"Reprod Toxicol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-019-0597-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13048-019-0597-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-019-0597-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:39:48Z","timestamp":1607647188000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-019-0597-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["597"],"URL":"https:\/\/doi.org\/10.1186\/s13048-019-0597-y","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"20 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was reviewed and approved by Ethics committee\/Institutional Review Board of Yamaguchi University School of Medicine (H22\u2013165), and the study was conducted according to guidelines as stated in the Declaration of Helsinki. Written informed consent was provided by all subjects prior to study inclusion.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}